Evidence map›Paper›PMID 39595938›Full record

ArticleInternational journal of molecular sciences2024

In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin (

Marta Budzińska, Agnieszka Malcher, Agnieszka Zimna, Maciej Kurpisz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marta BudzińskaInstitute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.
Agnieszka MalcherInstitute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0002-3433-6990
Agnieszka ZimnaInstitute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0003-3778-4470
Maciej KurpiszInstitute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0003-3275-3245

Funding

National Science Centre 2017/25/B/NZ5/01131
6 · The paper itself

Abstract

Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by disruptions in the dystrophin gene. This study aims to investigate potential a therapeutic approach using genetically modified human iPS-derived mesoangioblast-like cells (HIDEMs) in

Indexed as

DystrophinGenetic TherapyInduced Pluripotent Stem CellsMice, Inbred mdxMuscular Dystrophy, DuchenneAnimalsCell DifferentiationDisease Models, AnimalGenetic VectorsHumansMaleMiceDystrophinDuchenne Muscular Dystrophygene therapymdx micemicrodystrophinmuscular dystrophy

Identifiers

PMID39595938
PMCPMC11593506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.